Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
| ▸ | MMP8 | P22894 | 3/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1003604 | 0.88 | CTSK (0.49) | CTSKCYP3A4CYP2C19CYP2C9ALDH1A1 | |
| SCHEMBL111212 | 0.86 | ALDH1A1 (0.50) | CTSKCYP3A4CYP2C19CYP2C9ALDH1A1 | |
| SCHEMBL7816238 | 0.85 | CTSK (0.45) | CTSKCYP3A4CYP2C19CYP2C9ALDH1A1 | |
| SCHEMBL7288405 | 0.85 | CTSK (0.47) | CTSKCYP3A4CYP2C19CYP2C9ALDH1A1 | |
| SCHEMBL3656311 | 0.85 | SMN1; SMN2 (0.48) | CTSKCYP3A4CYP2C19CYP2C9ALDH1A1 | |
| SCHEMBL3248705 | 0.84 | CYP3A4 (0.54) | CTSKCYP3A4CYP2C19CYP2C9ALDH1A1 | |
| SCHEMBL3833989 | 0.83 | TSHR (0.51) | CTSKCYP3A4CYP2C19CYP2C9ALDH1A1 | |
| SCHEMBL16212885 | 0.83 | TDP1 (0.50) | CTSKCYP2C19ALDH1A1HIF1ASMN1; SMN2 | |
| SCHEMBL872678 | 0.83 | KCNH2 (0.51) | CTSKCYP3A4CYP2C19CYP2C9ALDH1A1 | |
| SCHEMBL28196662 | 0.83 | CYP3A4 (0.45) | CTSKCYP3A4CYP2C19CYP2C9CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12603321-B2 | Battery separators, electrodes, cells, lithium batteries and related methods | CELGARD, LLC (US) | 2026-04-14 | — | — | US | claimed |
| US-8383276-B2 | High voltage electrolyte | TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) | 2013-02-26 | — | — | US | claimed |
| US-8288040-B2 | High voltage electrolyte | TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) | 2012-10-16 | — | — | US | claimed |
| US-20110008680-A1 | HIGH VOLTAGE ELECTROLYTE | TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) | 2011-01-13 | — | — | US | claimed |
| US-20100209780-A1 | HIGH VOLTAGE ELECTROLYTE (Muldoon, Allred) | TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) | 2010-08-19 | — | — | US | claimed |
| US-20260149126-A1 | POLYIMIDE COATED SEPARATORS, POROUS POLYIMIDE COATINGS, LITHIUM BATTERIES, AND RELATED METHODS | CELGARD, LLC (US) | 2026-05-28 | — | — | US | disclosed |
| US-12603321-B2 | Battery separators, electrodes, cells, lithium batteries and related methods | CELGARD, LLC (US) | 2026-04-14 | — | — | US | disclosed |
| US-12555872-B2 | Polyimide coated separators, porous polyimide coatings, lithium batteries, and related methods | CELGARD, LLC | 2026-02-17 | — | — | US | disclosed |
| US-20250316845-A1 | COATED MICROPOROUS MEMBRANES, AND BATTERY SEPARATORS, BATTERIES, VEHICLES, AND DEVICES COMPRISING THE SAME | CELGARD LLC (US) | 2025-10-09 | — | — | US | disclosed |
| US-20250246760-A1 | COATED MICROPOROUS MEMBRANES, AND BATTERY SEPARATORS, BATTERIES, VEHICLES, AND DEVICES COMPRISING THE SAME | CELGARD LLC (US) | 2025-07-31 | — | — | US | disclosed |
| US-20240329146-A1 | IMPROVED BATTERIES, CELLS, COMPONENTS, AND TESTING THEREOF | CELGARD, LLC | 2024-10-03 | — | — | US | disclosed |
| US-20240313347-A1 | IMPROVED BATTERY CELLS AND COMPONENTS THEREOF | CELGARD, LLC | 2024-09-19 | — | — | US | disclosed |
| EP-3535792-A1 | BATTERY SEPARATORS | Celgard, LLC (US) | 2019-09-11 | — | — | EP | disclosed |
| US-8383276-B2 | High voltage electrolyte | TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) | 2013-02-26 | — | — | US | disclosed |
| US-8288040-B2 | High voltage electrolyte | TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) | 2012-10-16 | — | — | US | disclosed |
| US-20120183866-A1 | Fluorinated Arylboron Oxalate as Anion Receptors and Additives for Non-Aqueous Battery Electrolytes | Brookhaven Science Associates ,LLC (US) | 2012-07-19 | — | — | US | disclosed |
| WO-2011031401-A2 | LITHIUM NON-FLUORINATED AND FLUORINATED PHENYL TRIFLUORO BORATE SALTS FOR NON-AQUEOUS BATTERY ELECTROLYTES | BROOKHAVEN SCIENCE ASSOCIATES LLC (US) | 2011-03-17 | — | — | WO | disclosed |
| WO-2011014451-A2 | FLUORINATED ARYLBORON OXALATE AS ANION RECEPTORS AND ADDITIVES FOR NON-AQUEOUS BATTERY ELECTROLYTES | BROOKHAVEN SCIENCE ASSOCIATES LLC (US) | 2011-02-03 | — | — | WO | disclosed |
| US-20110008680-A1 | HIGH VOLTAGE ELECTROLYTE | TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) | 2011-01-13 | — | — | US | disclosed |
| US-20100209780-A1 | HIGH VOLTAGE ELECTROLYTE (Muldoon, Allred) | TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) | 2010-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12555872-B2 | Polyimide coated separators, porous polyimide coatings, lithium batteries, and related methods | DCX, GABRE, DYNC1I2 | CTSK 3782/4885CYP3A4 4804/4885CYP2C19 4696/4885 |
| US-12603321-B2 | Battery separators, electrodes, cells, lithium batteries and related methods | NES, LNPK, NEK9 | CTSK 313/4885CYP3A4 4710/4885CYP2C19 4184/4885 |
| US-20260149126-A1 | POLYIMIDE COATED SEPARATORS, POROUS POLYIMIDE COATINGS, LITHIUM BATTERIES, AND RELATED METHODS | GABRE, DCX, DYNC1I2 | CTSK 3806/4885CYP3A4 4809/4885CYP2C19 4656/4885 |
| US-20120183866-A1 | Fluorinated Arylboron Oxalate as Anion Receptors and Additives for Non-Aqueous Battery Electrolytes | SLCO2B1, SLCO1B1, SLCO4C1 | CTSK 2685/4885CYP3A4 1186/4885CYP2C19 416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.